Cargando…
Potential Therapeutic Targets of B7 Family in Colorectal Cancer
Programmed cell death protein 1 (PD-1)/programmed death ligand 1 (PD-L1) pathway blockade has impressively benefited cancer patients with a wide spectrum of tumors. However, its efficacy in colorectal cancer (CRC) is modest, and only a small subset of patients benefits from approved checkpoint inhib...
Autores principales: | Wang, Changgang, Feng, Haoran, Cheng, Xi, Liu, Kun, Cai, Dongli, Zhao, Ren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232583/ https://www.ncbi.nlm.nih.gov/pubmed/32477326 http://dx.doi.org/10.3389/fimmu.2020.00681 |
Ejemplares similares
-
Targeting tumor cell-derived CCL2 as a strategy to overcome Bevacizumab resistance in ETV5(+) colorectal cancer
por: Feng, Haoran, et al.
Publicado: (2020) -
Correction: Targeting tumor cell-derived CCL2 as a strategy to overcome Bevacizumab resistance in ETV5(+) colorectal cancer
por: Feng, Haoran, et al.
Publicado: (2020) -
Phenotypic and Functional Analyses of B7S1 in Ovarian Cancer
por: Cai, Dongli, et al.
Publicado: (2021) -
The role of E26 transformation-specific variant transcription factor 5 in colorectal cancer cell proliferation and cell cycle progression
por: Peng, Yi, et al.
Publicado: (2021) -
ETV1 Positively Correlated With Immune Infiltration and Poor Clinical Prognosis in Colorectal Cancer
por: Shen, Xiaonan, et al.
Publicado: (2022)